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Abstract
As in human disease, macrophages (MØ) are central players in the development and progression of experimental
atherosclerosis. In this study we have evaluated the phenotype of MØ associated with progression of atherosclerosis in
the apolipoprotein E (ApoE) knockout (KO) mouse model. We found that bone marrow-derived MØ submitted to M1
and M2 polarization specifically expressed arginase (Arg) II and Arg I, respectively. This distinct arginase expression was
used to evaluate the frequency and distribution of M1 and M2 MØ in cross-sections of atherosclerotic plaques of ApoE KO
mice. Early lesions were infiltrated by Arg I+ (M2) MØ. This type of MØ favored the proliferation of smooth muscle cells, in
vitro. Arg II+ (M1) MØ appeared and prevailed in lesions of aged ApoE KO mice and lesion progression was correlated
with the dominance of M1 over the M2 MØ phenotype. In order to address whether the M2-.M1 switch could be due to
a phenotypic switch of the infiltrated cells, we performed in vitro repolarization experiments. We found that fully
polarized MØ retained their plasticity since they could revert their phenotype. The analysis of the distribution of Arg I-
and Arg II-expressing MØ also argued against a recent recruitment of M1 MØ in the lesion. The combined data therefore
suggest that the M2-.M1 switch observed in vivo is due to a conversion of cells already present in the lesion. Our study
suggests that interventional tools able to revert the MØ infiltrate towards the M2 phenotype may exert an
atheroprotective action.
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Introduction
Apolipoprotein E (ApoE) knockout (KO) mice spontaneously
develop atherosclerotic lesions and are widely used to study
atherosclerosis. Lack of ApoE results in severe hypercholesterol-
emia which is necessary for the development of the disease.
However, in the absence of macrophages (MØ), the severe
hypercholestoremia is not sufficient to drive the pathologic process
in this model [1], demonstrating that these cells exert essential
functions during atherogenesis. Infiltrating MØ scavenge oxida-
tively-modified self-compounds accumulated in the arterial wall
and are converted into foam cells, the first cells forming
atherosclerotic lesions. In the last few years, it has become widely
accepted that classically activated MØ (or M1) and alternatively
activated MØ (or M2) are two extremes (inflammatory and
reparative, respectively) of a spectrum of possible MØ phenotypes
[2,3]. A major effector molecule of inflammatory MØ is NO,
which is synthesized by inducible NO synthase (iNOS) from L-
arginine (L-Arg). In addition, MØ express arginases, which also
catalyze L-Arg. There are two isoforms of arginase, arginase I (Arg
I) is cytosolic and arginase II (Arg II) is mitochondrial. While this
intracellular compartmentalization might endow them with
distinct biological activities, they both transform L-Arg into L-
ornithine, a precursor of polyamines and proline. Polyamines are
involved in cell growth, differentiation and division whereas
proline is a key component of collagen. Since a predominant
expression of arginase over that of iNOS was reported in
alternatively activated MØ [4] and a change in the L-Arg
metabolism has been proposed to be an important component of
wound healing [5], M2 MØ have been classified as reparative
cells.
In the present study, we found that bone marrow-derived MØ
submitted to M2 polarization conditions exclusively express the
Arg I isoform and no iNOS. Conversely, M1 MØ expressed Arg II
in addition to iNOS but did not express Arg I. This differential
arginase isoform expression was exploited to establish the
phenotype of MØ infiltrated in atherosclerotic plaques of young
and aged ApoE KO mice.
Lesion-infiltrated MØ of young ApoE KO mice were virtually
all Arg I+ suggesting that they were of the M2 phenotype. This
type of MØ favored the proliferation of smooth muscle cells, in
vitro. Arg II+ (M1) MØ appeared and prevailed in lesions of aged
ApoE KO mice. Additional data suggest that this M2-.M1 switch
is due to a change in the cytokine milieu that triggers the
conversion of the MØ already present in the lesion. Finally, lesion
progression was correlated with the dominance of M1 over the M2
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infiltrated MØ. These observations indicate that interventional
tools able to favor the M2 MØ phenotype may exert an
atheroprotective action.
Results
Arg I and Arg II Are Respectively Expressed by M2 and
M1 Macrophages
In preliminary methodological studies, we found that bone
marrow-derived MØ from C57BL/6 mice produced Arg I and
Ym1/2 (a member of the chitinase family expressed by M2 MØ
[6]) when subjected overnight to IL-4 (pro-M2 polarizing
conditions), and Arg II after LPS stimulation (pro-M1 polarizing
conditions). In these experiments, polarizing stimuli were applied
on IFNc-primed MØ as described by the group of Mosser [7].
Since this IFNc priming step could conceivably bias the
polarization, this parameter was tested (Fig. 1A). We found that
the IFNc priming enhanced Arg I expression in MØ subjected to
M2 polarizing conditions without major changes in iNOS, Arg II
and Ym1/2 expression. On the other hand, this step increased the
iNOS expression of M1 polarized MØ and decreased their Arg II
expression, as previously reported by Wang et al [8] (Fig. 1A).
Non-polarized M0 MØ did not express any of these genes and the
IFNc priming step had no effect. The IFNc priming step was used
in the following experiments since it further discriminates between
M0, M1 and M2 phenotypes in vitro.
Medium Conditioned by M2 Macrophages Induces the
Proliferation of Vascular Smooth Muscle Cells
To test whether the predominance of the arginase expression
over that of the iNOS endowed M2 MØ with reparative
capabilities, vascular smooth muscle cells (VSMCs) were cultured
with MØ-conditioned medium. M2-conditioned medium induced
the proliferation of VSMCs (Fig. 1B) and of adventitial fibroblasts
(data not shown). By contrast, M1-conditioned medium did not
affect cell proliferation (Fig. 1B and data not shown). The effect
was not due to the presence of LPS/IFNc or IL-4 in the
conditioned media since, alone, these agents were not able to
induce cell proliferation (Fig. 1B).
ApoE KO Macrophages Are M2-Prone
The distinct expression of arginase isoforms by M1 and M2
macrophages could be used to establish the phenotype of
macrophages infiltrated in the lesions of apoE KO mice. A
prerequisite to use the arginase isoforms as M1 and M2 markers is
that their distinct expression holds true for MØ of apoE KO mice.
To address this issue, we explored kinetically (2, 4, 6, 24 and 48 h)
the expression of Arg I, Arg II, iNOS and IL-6 in polarized bone
marrow-derived MØ from C57BL/6 (MØB6) and ApoE KO
(MØApoE) mice.
As expected, the transcription of iNOS and Arg II, but not of
Arg I, and the production of IL-6 were observed in M1-polarized
MØB6, with a peak expression at 10 hours (Fig. 2). In contrast, no
IL-6 was produced by M2-polarized MØ and Arg I was the only
transcript observed in M2-polarized MØB6, exhibiting similar
kinetics (Fig. 2).
Lack of ApoE influenced the quantitative rather than the
qualitative response to the polarizing agents. M1 MØApoE
displayed global (Arg II + iNOS) M1 gene expression levels close
to those of MØB6 (Fig. 2). The high expression of Arg II in M1
MØApoE confirmed that it can be a reliable marker of the M1
phenotype in atherosclerotic lesions. MØ from ApoE KO mice
appeared to be M2-prone since M2 polarization induced a
markedly higher Arg I expression in MØApoE compared to MØB6.
Figure 1. Phenotypic and functional features of M1 and M2
macrophages. A: The effect of an overnight IFNc priming step was
tested on C57Bl/6 mouse bone marrow-derived MØ subjected to M1-
or M2-polarizing conditions. The expression of iNOS, ArgI, ArgII, and
Ym1/2 were determined by real time RT-PCR on RNA extracted
10 hours after the induction of polarization. Data were calculated
using the 22DDCt Pfaffl formula [30] in which experimental conditions
(M1 and M2) are compared to Ct values obtained in M0 MØ and
normalized to the Ct values of the HPRT house-keeping gene. B:
Primary aortic vascular smooth muscle cells (VSMCs) from C57Bl/6
mice were cultured for 48 hours in the presence of media conditioned
by C57Bl/6 M1 or M2 MØ which were polarized in the presence of the
PPARc agonist pioglitazone (Pio), the PPARc antagonist GW9662 (GW),
or the arginase inhibitor Nor-NOHA. As controls, VSMCs were also
cultured with the same concentration of the polarizing agents, of the
PPARc agonists and antagonists, or of the arginase inhibitor. At the
end of the assay, the number of viable cells in each condition was
evaluated by the MTT assay and by using a standard curve established
with known numbers of cells. *; **: p,0.05; p,0.01 vs matched
medium conditioned by MØ polarized in the standard way (2). Note
that the number of cells obtained with the M2-conditioned medium
were significantly greater than with M1-conditioned medium (p,0.01
vs matched condition).
doi:10.1371/journal.pone.0008852.g001
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Macrophage Phenotypes in Early and Advanced Plaques
in ApoE KO Mice
Since the two isoforms of the same enzyme appeared mutually
exclusive of M1 or M2 phenotype (Fig. 2), immunofluorescent
analysis of Arg I and Arg II expression (Fig. 3A) was used to
identify respectively M2 and M1 type MØ (Mac3+ cells) in aortic
root cryosections from 20 week-old (fatty streaks) and 55 week-old
(advanced plaques) ApoE KO mice.
At 20 weeks of age, lesions contained virtually only Arg I+ MØ
(Fig. 3B). At 55 weeks, the situation changed dramatically as a
considerable number of Arg II+ and Arg I+ Arg II+ double positive
MØwere detected (Fig. 3B). As expected, the surface area occupied
by MØ (Mac3+) was directly proportional to lesion size (Fig. 3C).
When considering the relative abundance of M2 over M1 MØ (Arg
I+ single positive/Arg II+ single positive ratio) it appeared that,
regardless of the disease stage, the prevalence of the M2 phenotype
was associated with smaller plaque surface areas (Fig. 3D).
In order to explore possible changes in the cytokine microen-
vironment during disease progression, the transcription levels of a
pro-M2 cytokine, IL-4 [9], and of a pro-M1 cytokine, IFNc [2],
were quantified by real time PCR on reverse-transcribed RNA
extracted from microdissected atherosclerotic lesions (Fig. 3F–I)
from 20 and 55 week-old ApoE KO mice.
As shown in Fig. 3E, IL-4 was the predominant transcript in
the atherosclerotic lesions of 20 week-old ApoE KO mice but it
decreased dramatically at 55 weeks of age. In contrast, IFNc
expression was undetectable in plaques of 20 week-old mice
whereas it became predominant in 55 week-old mice (Fig. 3E).
Effect of ApoE on the Macrophage Expression of PPARc
The more pronounced M2 potential of MØApoE suggested that
the response to IL-4 could be heightened in the absence of ApoE.
IL-4 can signal through two heterodimeric receptors composed of
the IL-4Ra chain complexed with either the common cc chain or
the IL-13Ra1 chain. As shown in Fig. 4A, the expression of IL-
4Ra and of IL-13Ra1 were similar in non-polarized MØ from the
two genotypes. This ruled out the possibility that the enhanced
response to IL-4 was dependent upon a distinct basal receptor
expression in MØApoE.
We next analyzed the expression level of transcription factors
downstream to the IL-4 receptor, in particular that of peroxisome
proliferator-activated receptor, PPARc, a member of the nuclear
receptor superfamily of transcription factors binding to fatty acids
and derivatives of cholesterol. We found that PPARc transcripts
were significantly increased in non-polarized MØApoE as com-
pared to MØB6 (Fig. 4B). The addition of exogenous ApoE
Figure 2. Kinetic expression of M1 and M2 markers. Bone marrow-derived MØ from C57BL/6 mice (MØB6, closed circles) and ApoE KO mice
(MØApoE, open circles) were differentiated, primed with IFNc and polarized or not (No polarization) towards the M1 (M1 polarization) or the M2
phenotype (M2 polarization). Expression of Arg I, iNOS, Arg II were determined by real time PCR and normalized by HPRT (au: arbitrary unit). IL-6 was
monitored in cell culture supernatant by ELISA. Results are representative of three independent experiments.
doi:10.1371/journal.pone.0008852.g002
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Figure 3. Macrophages of early atherosclerotic lesions in ApoE KO mice express Arg I while Arg II predominates in late stages. A:
Immunofluorescence of atherosclerotic lesions from 20 and 55 week-old ApoE KO mice. MØ were identified as Mac3+ (red) cells. Co-expression of
Mac3 and Arg I (violet) and/or Arg II (green) were identified by image overlay. Merge: overlay of bright field, DAPI, Mac3, Arg I and Arg II stainings.
Inset: magnification of the zone delimited in the ‘‘Merge’’ frame. B: Arg I, Arg II and Arg I+ Arg II+ double positive surface areas within 3 random fields/
plaque of 20 (white) and 55 (grey) week-old mice. C, D: Regression analysis between the surface area of plaques (X-axis) and total MØ area (Mac3, C)
or the Arg I+/Arg II+ ratio (D). R2: regression correlation coefficient. E: Expression of IL-4 and IFNc transcripts on microdissected atherosclerotic lesions
from 20 and 55 week-old ApoE KO mice determined by real time PCR and normalized by HPRT (au: arbitrary unit). **; ***: p,0.001; p,0.0001 vs 20 w.
F–I: Microdissection of aortic atherosclerotic lesions. Lesions can be detected (delimited by black dashes) through the vascular wall in the dissected
aortic root (white dashes). The vascular wall was opened longitudinally to expose the luminal side of the vessel (G). The aortic cusps are readily
identified. Arrow heads indicate the plane of fracture at the lesion/media interface, which allows the separation of the lesion from the media. The
arrows in H indicate the movement performed with tweezers to detach the lesion. Appearance of the vessel after the dissection of the lesion is shown
in I.
doi:10.1371/journal.pone.0008852.g003
Macrophage Plasticity
PLoS ONE | www.plosone.org 4 January 2010 | Volume 5 | Issue 1 | e8852
reduced the level of PPARc expression both in MØApoE and
MØB6 (Fig. 4B). As shown in Fig. 4C, addition of a PPARc
synthetic agonist, pioglitazone, further increased the expression of
Arg I in M2 MØ. Medium conditioned by these M2-polarized
MØ in the presence of pioglitazone increased the proliferation of
VSMCs (Fig. 1B). Conversely, inhibition of PPARc by GW9662
significantly reduced the expression of Arg I, regardless of the
polarization condition, but to a lesser extent in M2 MØ from
ApoE KO mice (Fig. 4C). PPARc inhibition also reduced the pro-
mitotic properties of M2 MØ-conditioned medium on VSMCs
(Fig. 1B). Of note, a selective arginase inhibitor, Nor-NOHA, also
significantly reduced the pro-mitotic activity of MØ- conditioned
medium (Fig. 1B) indicating that arginase activity contributes to
the pro-mitotic activity of MØ.
ApoE-Deficient Macrophages Retain Their Plasticity
In spite of the intrinsic M2 bias of MØ from ApoE KO mice, a
consistent number of Arg II+ (M1) MØ were detected in advanced
atherosclerotic lesions. This could be due to the recruitment of
MØ of different phenotypes during the course of the disease. We
therefore evaluated the location of Arg I and of Arg II labeling
within the plaque using a new quantification method (Fig. 5A),
assuming that newly recruited MØ would reside in the luminal
side of the plaque. While Arg I+ (M2) MØ accumulated in the
luminal side of the plaques in young mice, at 55 weeks of age, both
Arg I and Arg II labeling was evenly distributed across the plaque
(Fig. 5B) arguing against a sequential recruitment of MØ with
distinct phenotypes. Alternatively, the enrichment of advanced
atherosclerotic plaques in M1 MØ could be due to a phenotypic
conversion of plaque-infiltrated MØ. We therefore tested whether,
in the absence of ApoE, in vitro polarized MØ retain their
plasticity. Bone marrow-derived MØ were first polarized into M1
or M2 and subsequently subjected to a second and opposite
stimulation.
As in MØB6 mice, fully polarized MØ from ApoE KO mice
completely reverted from their the initial phenotype to the
opposite one after the second stimulation. After 10 h, M1 MØ
cultured with IL-4 turned on the expression of Arg I while the
expression of iNOS, Arg II and production of IL-6 were shut down
(Fig. 6, left). On the other hand, M2 MØ stimulated with LPS/
IFNc increased their expression of iNOS, Arg II, and IL-6 while
Arg I expression was considerably blunted (Fig. 6, right).
Therefore fully polarized MØ retained their plasticity regardless
of the absence of ApoE.
Discussion
It is well established that MØ play a key role in atherosclerosis
[1]. The present study corroborates this paradigm since we found
a direct correlation between the number of plaque-infiltrated MØ
and the size of the lesion. Such a positive correlation can be
interpreted as evidence for a pro-inflammatory and pathogenic
role of MØ in atherosclerosis. However, MØ are very versatile
cells with a high degree of plasticity in response to a range of
Figure 4. ApoE modulates the expression of PPARc. A: Expression of IL-4Ra1 and of IL-13Ra1 in non-polarized MØB6 and MØApoE determined
by real time PCR and normalized by HPRT (au: arbitrary unit). B: Expression of PPARc in non-polarized MØ from MØB6 (black) and MØApoE (white) mice
with increasing doses of recombinant ApoE (rApoE) determined by real time PCR and normalized by HPRT (au: arbitrary unit). **: p,0.001; ***:
p,0.0001 vs MØB6. C: Expression of ArgI in M1 and M2 MØB6 (black) and MØApoE (white) mice polarized with or without (2) pioglitazone (Pio) or
GW9662 (GW) determined by real time PCR. The Results are expressed as 22DDCt [30]. *: p,0.05; **: p,0.001 vs matched MØB6 condition; {: p,0.05;
{{: p,0.01 vs matched M1 condition.
doi:10.1371/journal.pone.0008852.g004
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environmental signals. Classically (M1) and alternatively (M2)
activated MØ represent the two extremes of a continuum of MØ
activation states, some of which can exert a beneficial effect [3]. In
the present study, we found that Arg I and Arg II were distinctly
upregulated in bone marrow-derived M1 and M2 MØ and used
them as surrogate markers of M1 and M2 MØ to evaluate
whether a particular phenotype of MØ is associated with the
progression of atherosclerotic disease.
Plaque-Infiltrated Macrophages Are Initially of the
Reparative Phenotype
Analysis of plaque-infiltrated MØ in young ApoE KO mice
revealed a uniform Arg I+ (M2) MØ phenotype. Concomitantly,
lesions consistently contained large amounts of IL-4. The source of
IL-4 at these sites could be either neutrophils [10] or NKT cells
[11], as suggested by recent studies showing the important
contribution of these cells to atherogenesis [12,13,14]. The
unexpected association of M2 reparative MØ with the initial
stages of atherogenesis does not necessarily imply that this MØ
phenotype contributes to the disease progression. Alternatively, we
propose that the M2 MØ exert a reparative action in
atherosclerosis since M2-conditioned medium promoted the
proliferation of vascular cells in vitro.
PPARc Favors the Reparative Macrophage Phenotype
In vitro polarization studies showed that the lack of ApoE favors
the reparative M2 phenotype in response to IL-4. The more
pronounced M2 potential of ApoE KO MØ was not due to
increased availability of the receptor to IL-4 but rather to an
increased expression of peroxisome proliferator-activated receptor
(PPAR)c, a major transcription factor downstream to the IL-4
receptor [15] and an emerging key regulator of MØ differenti-
ation, linking lipid metabolism and inflammation [16]. Addition of
a PPARc agonist (pioglitazone) further increased the expression of
Arg I of ApoE KO MØ in response to IL-4. Conversely, PPARc
inhibition by GW9662 reduced the expression of Arg I. In
agreement with previous studies performed on human MØ [17],
we propose that PPARc sustains the M2 activation pathway of
MØ in mice.
Interestingly, the addition of exogenous ApoE down-regulated,
in a dose-dependent manner, the levels of PPARc expression in
ApoE KO MØ and restored a feedback control exerted by ApoE
on this transcription factor. Indeed, this effect was also found in
MØ from wildtype mice, suggesting that ApoE exerts a
physiological control over PPARc transcription.
The Pro-Mitotic Activity of M2 Macrophages Is Related to
Their Expression of Arginase
We found that the pro-mitotic effect of M2 MØ-conditioned
medium on VSMCs was significantly reduced when MØ
polarization was performed in the presence of Nor-NOHA, an
arginase inhibitor, indicating that arginase activity contributes to
the pro-mitotic effect of M2 MØ. The experiments performed
with medium conditioned by MØ polarized in presence of
Figure 5. Distribution of Arg I+ and Arg II+ macrophages in atherosclerotic lesions. A: A new morphometric method was set up to analyze
the distribution of Arg I+ and Arg II+ MØ based on profiles (n = 10 per lesion, 3 lesions per mouse) outlined accross the lesions between the internal
elastic lamina (IEL) and the lumen border. To compare the profiles regardless of the lesion thickness, they were adjusted and represented according
to the percentage of the IEL-lumen border distance. Two profiles a and b are plotted as representative examples. B: Adjusted profiles showing the
Arg I and Arg II labeling distributions in the lesion in early (20w) and advanced (55w) aortic cusps of ApoE KO mice.
doi:10.1371/journal.pone.0008852.g005
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pioglitazone or of GW9662 corroborate this statement. Indeed,
medium conditioned by MØ polarized with pioglitazone,
expressing high levels of Arg I, induced a strong proliferation
of VSMCs. Instead, the proliferation of VSMCs was reduced
when these cells were cultured with medium conditioned by MØ
polarized with GW9662 expressing low levels of Arg I. The
reason why M1 MØ -conditioned medium failed to promote
VSMC proliferation is puzzling since M1 MØ express Arg II, an
enzyme that catalyzes the same reaction as Arg I. Given that
iNOS and arginases use L-Arg as a common substrate and given
their respective Km (,5 mmol/L vs 10 mmol/L) and Vmax
values (103–104 times higher for arginases), these enzymes are
expected to compete for L-Arg. Hence, iNOS may down-
regulate proline and polyamine production in M1 MØ by
competing with Arg II for L-Arg. The change of the arginase
isoform according to polarization could allow each MØ type to
distinctly address arginases to the cytosolic (Arg I) or
mitochrondrial (Arg II) subcellular compartments where they
may exert distinct biological effects as reported in endothelial
cells [18].
Macrophage Phenotypic Switch Correlates with Lesion
Progression
With disease progression, Arg II+ (M1) MØ prevailed over the
Arg I+ (M2) MØ. Regression analysis showed that the M2/M1
ratio of plaque-infiltrated MØ is inversely proportional to the
progression of lesion size in apoE KO mice, indicating that plaque
growth is linked to the enrichment in pro-inflammatory M1 MØ.
The enrichment of the advanced atherosclerotic plaque in Arg
II+ (M1) MØ could be due to a phenotypic conversion of plaque-
infiltrated, polarized MØ. This hypothesis is supported by the fact
that Arg I can be co-detected with Arg II (double positive staining)
in MØ present in advanced plaques. This finding is reminiscent of
what we found in vitro: M2 cells repolarized to the M1 phenotype
maintain a certain level of Arg I expression, which is absent in
directly polarized M1 MØ. MØ plasticity has been extensively
described in wildtype cells [19,20,21]. While IFNc promotes the
M1 phenotype in MØ, IL-4 induces the M2 phenotype [2,22].
Importantly, the plaque cytokine microenvironment changed over
time, since we documented a local increase in the expression of
IFNc at the expense of IL-4 within advanced atherosclerotic
Figure 6. Preserved plasticity of fully polarized macrophages. MØApoE (white) and MØB6 (black) were primed and subjected to a first M1 or
M2 polarization. After ten hours, the culture conditions were switched during 10 additional hours in order to induce the opposite phenotype.
Expression of iNOS, Arg I and ArgII was evaluated by real time PCR and normalized by HPRT (au: arbitrary unit). Results are representative of three
distinct experiments.
doi:10.1371/journal.pone.0008852.g006
Macrophage Plasticity
PLoS ONE | www.plosone.org 7 January 2010 | Volume 5 | Issue 1 | e8852
plaques. Alternatively, the change in the phenotype of plaque
infiltrating MØ in advanced lesions could result from newly
recruited M1 MØ. If this were the case, one would expect M1 cells
to be present mainly in the luminal side. We found that both Arg I
and Arg II labeling was evenly distributed across the advanced
lesions. These data thus do not support a sequential recruitment of
M2 and of M1 MØ over time. We however cannot definitively
rule out the possibility that a change in the local cytokine milieu
differentially polarizes new incoming monocytes. Thus, we
propose that the initial MØ phenotype is of the M2 type and
the changes in the cytokine milieu of the advanced plaque favor
the emergence of pro-inflammatory M1 MØ, the prevalence of
which is directly correlated with plaque growth.
In the present study, we used Arg I and Arg II as surrogate
markers of M1 and M2 MØ since these two isoforms of arginase
were distinctly upregulated in bone marrow-derived M1 and M2
MØ polarized in vitro. However, it has been shown that IFNc and
LPS differently modulate Arg II expression in M1 MØ [8] and
that Arg I can be expressed by MØ that have been activated
independently of M2-polarizing conditions (IL-4/IL-13) [23,24].
Therefore, we cannot formally exclude that Arg I+ and Arg II+
MØ observed in vivo may also reflect MØ activation states that
differ from the ones obtained by the polarization conditions that
we used in vitro.
Macrophage Plasticity in Atherosclerosis:
Pathophysiologic and Therapeutic Considerations
The phenotypic change of plaque MØ might depend upon the
type (innate or adaptative) of the immune effectors infiltrating the
developing lesion. It is of interest that a recent study by Loke et al.
showed that the initial M2 MØ phenotype at the site of
inflammation is independent of the cells of the adaptive immune
system whereas the maintenance of the M2 MØ phenotype
requires IL-4-producing T cells, in the absence of which M2 MØ
switch to the M1 phenotype [25]. Transposing this mechanism to
atherosclerosis suggests that the Th1 phenotype might trigger the
M2-.M1 phenotypic switch in advanced atherosclerotic plaques,
when the effectors of the innate immunity hand over the relay to
the effectors of the adaptive immune system [26].
In a therapeutic perspective, controlling the local cytokine
milieu within atherosclerotic plaques in vivo will be difficult to
achieve. On the other hand, a recent histopathologic study on
human carotid plaques [17], has suggested that PPARc activation
may skew MØ polarization toward the M2 phenotype. The
present experimental study demonstrates that PPARc agonists,
which are already being employed in clinical practice and have
shown an atheroprotective effect [27], do indeed potentiate the
response to M2 polarizing agents in mouse MØ. We therefore
propose that the use of PPARc agonists could contribute to the
stabilization of atherosclerotic lesions by favoring the differentia-
tion and/or conversion of plaque-infiltrated MØ into the
reparative M2 phenotype.
Methods
Analysis of Atherosclerotic Lesions
Immunohistochemistry and lesion morphology analysis were
performed as previously described [28] on serial aortic cryosec-
tions from 20 (n = 10) or 55 (n= 10) week-old ApoE KO mice
(obtained from the Jackson Laboratory and bred in our facility)
maintained on a regular chow diet. Mice were handled in
accordance with European Union directives (86/609/EEC) on the
care and use of laboratory animals. The investigation was
approved by the Animal Ethics Committee of the Institut National
de la Sante´ et de la Recherche Me´dicale. The review and approval
of the study was also obtained by the Local Animal Ethics
Committee (No. B 7518 03).
Immunohistology
Cryosections were fixed in acetone, delipidized with alcohol and
toluene, and re-hydrated. Endogenous peroxidase and avidin/
biotin were blocked using commercial Kits (DAKO). When using
mouse anti-mouse antibodies, slides were pre-incubated with a
F(ab)’2 fragment-goat anti-mouse IgG (Jackson immunoResearch)
and the M.O.M. immunodetection Kit (Vector Laboratories). Arg
I+ and Arg II+ MØ were identified with a purified rat anti-mouse
Mac3 monoclonal antibody (BD Biosciences), an immunopurified
rabbit anti-mouse Arg II polyclonal antibody [29], and a purified
mouse anti-mouse ArgI monoclonal antibody (BD). The staining
was revealed by using fluorescent secondary antibodies (Molecular
Probes): Alexa Fluor 647 goat anti-rat IgG (H+L) for Mac3, Alexa
Fluor 546 anti-mouse for Arg I and Alexa Fluor 488 goat anti-
rabbit for ArgII. Immunostained slides were cover-mounted with
Prolong Gold antifade reagent (Invitrogen). The fluorescence was
detected with a Zeiss Axiovert 200 M microscope equipped with
the AxioCamMRm vers.3 camera, the ApoTomeH system and the
AxioVisionH image capture software. Images were acquired using
the EC ‘‘Plan-Neofluar’’ 40x/0,75 (df = 0,71 mm) objective of the
microscope.
In order to evaluate the spatial distribution of Arg I and Arg II
labeling within the plaque, we have set up a morphometric
method based on intensity profiles of each immunostain and a
normalization of the distance between the internal elastic lamina
(IEL) and the luminal border of the plaque. To this purpose, we
have quantified by computer-assisted image analysis the profiles
over 10 segments (mean convergence $7) crossing the plaques of
each aortic cusp of each mouse (30 profiles/immunostain/mouse;
Fig. 5A).
Bone Marrow-Derived Macrophage Isolation and
Differentiation
Primary cultures of bone marrow-derived MØ were obtained
from femurs of 6–10 week-old C56BL/6 (B6, Janvier) or ApoE
KO mice as described [20] and cultured in complete medium
(MEM supplemented with 10% FCS, 800 pg/ml Macrophage-
Colony Stimulating Factor-1 [20% L-929-conditioned medium]).
Non-adherent cells were collected after 24 h and were differen-
tiated for 7 days yielding 98% Mac3+, 98% F4/80+ and 99%
CD11b+ cells (data not shown).
Polarization of Bone Marrow-Derived Macrophages
Differentiated bone marrow-derived MØ were polarized with
either 100 ng/ml LPS+100 U/ml IFNc (M1) or 5 ng/ml IL-4
(M2) [2]. The effect of an overnight priming with 100 U/ml IFNc
prior to polarization [7] was also tested. Non-polarized MØ were
cultured in complete medium alone.
To test the effect of PPARc, a pharmacological agonist
(pioglitazone, 1 mM) or an antagonist (GW9662, 1 mM) were
added 2 hours before the polarization, which was performed as
described above.
Human recombinant ApoE (rApoE) was desalted to eliminate
the toxic ammonium bicarbonate and was used at 0.03 and
30 mM.
For MØ plasticity studies, cells were cultured in the pro-M1
conditions described above for 10 hours, washed and then
submitted for an additional 10 hours to the pro-M2 environment
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(M1 -.M2). The experiment was mirrored to study the M2 -.M1
switch.
At the end of the stimulation, culture supernatants were
collected and stored at 280uC prior to IL-6 analysis (ELISA,
BD Biosciences). MØ were washed and lysed in Trizol for RNA
extraction and analysis of gene expression.
Gene Expression Studies
Total RNA from cells or atherosclerotic lesions microdissected
from the ascending aorta just above the aortic cusps (Fig. 3F–I)
was isolated and reverse-transcribed using Superscript II reverse
transcriptase. Real time PCR was performed on cDNA with the
primer pairs listed in Table 1 on a CFX 100 (Biorad) or a
SDS7700 (Applied Biosystems) cycler (2 ml cDNA, 250 nM
primers, 11 ml Syber-Green master mix from Qiagen; 1 cycle:
50uC, 2 min, 1 cycle: 95uC 15 min, and 60 cycles: 95uC 40 s,
60uC 1 min). Dissociation curve analysis was performed at the end
of 60 cycles to verify the identity of the PCR product. No signals
were detected in no-template controls. When results concerning
the three M0, M1 and M2 conditions were required, 4 serial J
dilutions of a cDNA control sample were used to establish a
standard curve in each reaction. Expression of genes of interest
was normalized to the level of expression of the constitutively
expressed hypoxanthine-guanine phosphoribosyltransferase
(HPRT) gene and are expressed as arbitrary units (au). When
M1 and M2 conditions were expressed as compared the M0
reference, the 22DDCt formula as described by Pfaffl MW [30] was
applied, where threshold cycle ‘‘Ct’’ values correspond to the cycle
at which PCR enters the exponential phase.
Arterial VSMC Proliferation
Primary vascular smooth muscle cells were obtained from
explant cultures of aortic tissue from C57BL/6 mice as described
[31] without the enzymatic digestion step. The full length of the
thoracic aorta was aseptically dissected and the adventitia was
removed. The aorta was cut into small segments (,1 mm3), which
were incubated for 1 h at 37uC in 5% CO2 in a drop of 10% FCS
DMEM and then cultured in standard conditions for 2 weeks.
VSMCs were trypsinized, seeded at an initial density of
5,000 cells/well in 96-well plates and grown to sub-confluence (2
days). Cells were then left quiescent for 48 h in 1% FCS DMEM.
Culture medium conditioned by M0, M1, or M2 MØ, harvested
10 h after polarization, were added to the VSMCs for 48 h. In
certain wells, the medium was conditioned by MØ polarized in the
presence of 50 mM or 100 mM Nor-NOHA, a specific arginase
inhibitor or in the presence of 1 mM pioglitazone or 1 mM
GW9662. Control wells included VSMCs cultured in the presence
of 100 ng/ml LPS+100 U/ml IFNc,5 ng/ml IL-4, 50 or 100 mM
Nor-NOHA, 1 mM pioglitazone, or 1 mM GW9662 in serum free
medium (BSA 4%) to test whether the molecules used during the
polarization of MØ still remaining in the MØ-conditioned
medium had a direct effect on cell proliferation. At the end of
the assay, the number of viable cells in each condition was
evaluated by the reduction of the dye 3-[4,5-dimethylthiazol-2-yl]-
2,5 diphenyltetrazolium (MTT tetrazolium, 0.5 mg/ml final
concentration in wells) [32] and by using a standard curve
established with known numbers of cells (8 wells ranging from
1000 up to 80 000 VSMCs). MTT was incubated for 3 hours at
37uC, the medium removed, and the formazan product dissolved
in 100 ml DMSO. Product formation was assessed spectrophoto-
metrically by measuring the OD at 590 nm.
Statistical Analysis
Results are expressed as means 6 SEM. Differences between
groups were evaluated by one-way ANOVA. Differences were
considered significant when p,0.05. Correlations between
continuous variables were calculated by regression. Statistical
analysis was performed using Statview 5.0 Software (SAS Institute
Inc., USA).
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